Navigation Links
ERT Reports Second Quarter 2011 Operating Results
Date:8/1/2011

205 29   Stock option income tax benefit2 2   Repurchase of common stock for treasury-   (46)Net cash provided by financing activities23,217 595 Effect of exchange rate changes on cash(2,553),817 Net (decrease) increase in cash and cash equivalents(46,475),258 Cash and cash equivalents, beginning of period8,979 30,343 Cash and cash equivalents, end of period $
22,504 $
31,601 eResearchTechnology, Inc. and SubsidiariesReconciliation of GAAP to Non-GAAP Information (in thousands, except per share amounts)(unaudited)Three Months EndedSix Months EndedJune 30,   2010

March 31, 2011

June 30,   2011June 30,
2010

June 30,
2011Net revenues$
29,096

$
41,699

$
42,849$
50,964

$
84,548Reconciliation of GAAP to Non-GAAP gross margin:GAAP gross margin$
5,814

$
8,420

$
,045$
27,572

$
34,465Amortization of acquired intangibles and other assets833

1,878

1,970833

3,848Non-GAAP gross margin$
,647

$
20,298

$
8,015$
28,405

$
38,313Non-GAAP gross margin percentage57.2%

48.7%

42.0%55.7%

45.3%Non-GAAP gross margin percentage is calculated by dividing non-GAAP gross margin by net revenues-Reconciliation of GAAP to Non-GAAPoperating income:GAAP operating income$
,051

$
5,354

$
2,570$
3,798

$
7,924Amortization of acquired intangibles and other assets833

1,878

1,970833

3,848Acquisition and integration related costs3,840

-

-4,581

-Non-GAAP operating income$
5,724

$
7,232

$
4,540$
9,212

$
,772Non-GAAP operating income margin percentage19.7%

17.3%

10.6%18.1%

13.9%Non-GAAP operating income margin percentage is calculated by dividing non-GAAP operating income by net revenues-Reconciliation of GAAP to Non-GAAP net income:GAAP net income$
826'/>"/>

SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health care ... new IT value-added reseller (VAR) national contracts that expand ... and services at lower costs. These include manufacturer product ... as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... 15, 2014  Manufacturers, suppliers and distributors of innovative ... protect their most important business assets, intellectual property ... Because of the highly-competitive nature of ... of the most litigious industry sectors of cases ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
... , LAKE FOREST, Ill., Dec. 16 Hospira, ... pharmaceutical and medication delivery company, today announced that it will ... 2009 results and projections for 2010 on Thursday, Feb. 4, ... release its fourth-quarter and full-year 2009 results earlier that morning, ...
... , GREEN BAY, Wis., Dec. ... with DolCas Biotech for the use of super ... multiple EuroPharma formulations. The exclusive distribution territory ... food store channel and professional channel, which includes ...
Cached Medicine Technology:EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3
(Date:4/17/2014)... Colic affects about one in five infants in the ... during the first several months after birth. Research into ... promise; however, the April 1, 2014 issue of the ... on a study, "Probiotics and Infant Colic," concluding that ... for infant colic did not reduce crying or ...
(Date:4/17/2014)... by researchers at UC Davis has shown that the ... in cell division, also boosts the mitochondrial activity to ... complex has been shown to perform both jobs. This ... to control cellular energy production, potentially advancing cancer care ... in the journal Developmental Cell . , "These ...
(Date:4/17/2014)... days to find a colored ribbon representing a disease. A ... what color ribbon does one think of with lung cancer?, ... many suffering from the disease, black may be the only ... of lung cancer patients, primarily smokers between the ages of ... the stigma often felt by these patients, the emotional toll ...
(Date:4/17/2014)... study has found that India,s shocking rates of suicide ... who are clinging to tiny smallholdings less than ... such as cotton and coffee, that are highly susceptible ... range of previous case studies that point to a ... the ,liberalisation, of the nation,s economy during the 90s. ...
(Date:4/17/2014)... the leading weapon against the deadly disease could be ... indicating it simply needs to be administered differently. , ... anti-malarial drug chloroquine in treating and preventing the mosquito-bourne ... a million people each year around the world. , ... chloroquine, but research carried out at the Australian National ...
Breaking Medicine News(10 mins):Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Scientists find new way to fight malaria drug resistance 2
... over-the-counter pain killers should carry warnings that they ... comments follow a study by Danish reseacher Gunnar ... British Medical Journal which studied the effect on ... indomethacin (ibuprofen). ,Researchers used prescription //records to ...
... from the University of Chapel Hill have found ... appear to worsen the outcome. ,The study tracked two ... had lower back pain for over six weeks. One group ... that after three months, patients who had initially received the ...
... Pharmaceuticals. Baycol, which was initially approved by the FDA, ... cholesterol by blocking enzymes that are essential in the ... has voluntarily recalled its cholesterol drug Baycol( cerivastatin ) ... deaths. Baycol can cause a muscular side effect called ...
... stimuli also affect the appetite centre of the brain.,It is ... often accompanies pain. People with migraine, for instance, cannot face ... one common linked symptom is nausea. ,Scientists at ... reveal, in a study,// the changes in the brain when ...
... Carolina at Chapel Hill, state about the discovery of how ... The UNC scientists have found a previously unknown ... the genetic messenger known as RNA. When the chemical ... which the information contained in DNA,is converted into functions critical ...
... research has found that young women are much more likely ... which contradicts the stereotype that men are more likely to ... Internal Medicine this week. ,Researchers from Emory, Yale and ... were discharged from hospital after a heart attack. They found ...
Cached Medicine News:
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
... a rapid, real-time thermal cycler used for ... automating much of the testing process, and ... is the fastest, easiest to use, and ... The SmartCycler delivers highly accurate and consistent ...
... Real-Time PCR System gives you advanced, ... budget sensitivity. , , Four-color detection ... analysis, pathogen quantitation, SNP genotyping, and ... , Powerful, versatile software including ...
... of SYBR Green I or FAM in ... fluorophores in the second channel including ... a multitude of applications such as RT-qPCR ... offers precision thermal control and a temperature ...
Medicine Products: